1-9 of 9
Luisa Viterbo
Close
Sort by
Journal Articles

The Magnitude of Lactate Dehydrogenase Elevation As a Predictive Factor for Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Iolanda Vieira, Miguel Quintela, Cláudia Moreira, Sérgio Chacim, Nelson Domingues, Isabel Oliveira, Ana Espirito Santo, Maria Ilidia Moreira, Ângelo Martins, Maria Luisa Viterbo, Dulcineia Pereira, Jose Mario Mariz
Journal: Blood
Blood (2019) 134 (Supplement_1): 5342.
https://doi.org/10.1182/blood-2019-130993
Published: 2019
Journal Articles

High Risk DLBCL in Younger Patients: Should ASCT be Declined in the Era Pos-Rituximab?

Miguel Quintela, Iolanda Vieira, Cláudia Moreira, Sérgio Chacim, Nelson Domingues, Isabel Oliveira, Ana Espirito Santo, Maria Ilidia Moreira, Ângelo Martins, Maria Luisa Viterbo, Dulcineia Pereira, Jose Mario Mariz
Journal: Blood
Blood (2019) 134 (Supplement_1): 5356.
https://doi.org/10.1182/blood-2019-131254
Published: 2019
Journal Articles

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients

Clinical Trials & Observations
Hervé Avet-Loiseau, Nizar J. Bahlis, Wee-Joo Chng, Tamas Masszi, Luisa Viterbo, Ludek Pour, Peter Ganly, Antonio Palumbo, Michele Cavo, Christian Langer, Andrzej Pluta, Arnon Nagler, Shaji Kumar, Dina Ben-Yehuda, S. Vincent Rajkumar, Jesus San-Miguel, Deborah Berg, Jianchang Lin, Helgi van de Velde, Dixie-Lee Esseltine, Alessandra di Bacco, Philippe Moreau, Paul G. Richardson
Journal: Blood
Blood (2017) 130 (24): 2610–2618.
https://doi.org/10.1182/blood-2017-06-791228
Published: 2017
Includes: Supplemental data
Journal Articles

Higher c-MYC Expression Is Associated with Ixazomib-Lenalidomide-Dexamethasone (IRd) Progression-Free Survival (PFS) Benefit Versus Placebo-Rd: Biomarker Analysis of the Phase 3 Tourmaline-MM1 Study in Relapsed/Refractory Multiple Myeloma (RRMM)

Alessandra Di Bacco, PhD, Nizar J. Bahlis, MD, Nikhil C Munshi, MD, Hervé Avet-Loiseau, MD PhD, Tamás Masszi, MD, Luísa Viterbo, MD, Ludek Pour, MD PhD, Peter Ganly, BMBCh, PhD, Michele Cavo, MD, Christian Langer, MD, Shaji Kumar, MD, S. Vincent Rajkumar, MD, Deborah Berg, RN, MSN, Jianchang Lin, PhD, Bin Li, Sunita Badola, Lei Shen, Jacob Zhang, Ling Wang, PhD, Dixie-Lee Esseltine, MD, Katarina Luptakova, Helgi van de Velde, MD PhD, Paul G. Richardson, MD, Philippe Moreau
Journal: Blood
Blood (2016) 128 (22): 243.
https://doi.org/10.1182/blood.V128.22.243.243
Published: 2016
Journal Articles

Relapsed Follicular Lymphoma Treatment - with or without Hematopoietic Stem Cell Transplant?

Dulcineia Pereira, MD, Carolina Teixeira, MD, Sofia Ramalheira, MD, Patricia Rocha, Claudia Moreira, MD, Alina Rosinha, MD, Duarte Domingues, MD, Natasha Amaral, MD, Edgar Mesquita, MD, Ana Brito, MD, Luisa Viterbo, MD, Isabel Oliveira, MD, Nelson Domingues, MD, Ilidia Moreira, MD, Ana Espirito-Santo, MD, Sergio Chacim, MD, Luis Leite, MD, Isabel Cristina Ferreira, MD, Rui Henrique, PhD, Angelo Martins, MD, Jose Mario Mariz, MD
Journal: Blood
Blood (2014) 124 (21): 5893.
https://doi.org/10.1182/blood.V124.21.5893.5893
Published: 2014
Journal Articles

Advanced Stage Follicular Lymphoma - Watch and Wait or Immunochemotherapy?

Dulcineia Pereira, MD, Carolina Teixeira, MD, Sofia Ramalheira, MD, Patricia Rocha, Claudia Moreira, MD, Alina Rosinha, MD, Duarte Domingues, MD, Natasha Amaral, MD, Edgar Mesquita, MD, A Brito, MD, Luisa Viterbo, MD, Isabel Oliveira, MD, Nelson Domingues, MD, Ilidia Moreira, MD, Ana Espirito-Santo, MD, Sergio Chacim, MD, Luis Leite, MD, Isabel Cristina Ferreira, MD, Rui Henrique, PhD, Angelo Martins, MD, Jose Mario Mariz, MD
Journal: Blood
Blood (2014) 124 (21): 5476.
https://doi.org/10.1182/blood.V124.21.5476.5476
Published: 2014
Journal Articles

Proliferative Activity Of Neoplastic B Cells - Impact On The Prognosis Of Follicular Lymphoma

Dulcineia Pereira, MD, Sergio Pereira Chacim, MD, Margarida dantas Brito, ND, Miguel Abreu, MD, Edgar Mesquita, MSc, Margarida Marques, MD, Luisa Viterbo, MD, Isabel Oliveira, MD, Nelson Domingues, MD, Ilidia Moreira, MD, Ana Espirito-Santo, MD, Cecilia Correia, Carlos Palmeira, PhD, Emilia Sousa, Ines Godinho, Marta Pires, Rui Henrique, PhD, MD, Manuel R. Teixeira, MD PhD, Gabriela Martins, MD, Angelo Martins, MD, Jose Mario Mariz, MD
Journal: Blood
Blood (2013) 122 (21): 4321.
https://doi.org/10.1182/blood.V122.21.4321.4321
Published: 2013
Journal Articles

Genetic and Clinical Characterization of 45 Acute Leukemia Patients with MLL Gene Rearrangements From a Single Institution.

Nuno Cerveira, Susana Lisboa, Cecília Correia, Susana Bizarro, Joana Santos, Lurdes Torres, Joana Vieira, João D Barros-Silva, Dulcineia Pereia, Cláudia Moreira, Claus Meyer, Tereza Oliva, Ilída Moreira, Ângelo Martins, Luisa Viterbo, Vitor Costa, Rolf Marschalek, Armando Pinto, Jose Mario Mariz, Manuel R. Teixeira
Journal: Blood
Blood (2012) 120 (21): 2477.
https://doi.org/10.1182/blood.V120.21.2477.2477
Published: 2012
Journal Articles

Bortezomib, Thalidomide, and Dexamethasone (VTD) Versus VTD Plus Cyclophosphamide as Induction Therapy in Previously Untreated Multiple Myeloma Patients Eligible for HDT-ASCT: A Randomized Phase 2 Trial.

Heinz Ludwig, Luisa Viterbo, Richard Greil, Tamas Masszi, Ivan Spicka, Ofer Shpilberg, Roman Hajek, Anna Dmoszynska, Andrew Cakana, Christopher Enny, Huaibao Feng, Helgi van de Velde, Jean-Luc Harousseau
Journal: Blood
Blood (2009) 114 (22): 2312.
https://doi.org/10.1182/blood.V114.22.2312.2312
Published: 2009